Millennium Management’s CervoMed CRVO Stock Holding History

Millennium Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-208,908	Closed	-$823K	–	5941
2026 Q1	$823K	Buy	208,908 +148,640	+247%	+$776K	﹤0.01%	4513
2025 Q4	$476K	Sell	60,268 -11,241	-16%	-$90.3K	﹤0.01%	4973
2025 Q3	$579K	Sell	71,509 -4,571	-6%	-$39.2K	﹤0.01%	4986
2025 Q2	$478K	Buy	+76,080	New	+$648K	﹤0.01%	4945
2025 Q1	–	Sell	-18,463	Closed	-$43.2K	–	5946
2024 Q4	$43.2K	Buy	18,463 +2,894	+19%	+$28.1K	﹤0.01%	5610
2024 Q3	$227K	Buy	+15,569	New	+$241K	﹤0.01%	5367
2021 Q2	–	Sell	-4,454	Closed	-$307K	–	6596
2021 Q1	$307K	Buy	+4,454	New	+$374K	﹤0.01%	5196
2020 Q4	–	Sell	-221	Closed	-$14K	–	5244
2020 Q3	$14K	Buy	+221	New	+$16.8K	﹤0.01%	4361
2020 Q2	–	Sell	-800	Closed	-$19K	–	4216
2020 Q1	$19K	Buy	+800	New	+$24.3K	﹤0.01%	3736
2018 Q4	–	Sell	-205	Closed	-$100K	–	3808
2018 Q3	$100K	Buy	+205	New	+$95.3K	﹤0.01%	3736
2017 Q4	–	Sell	-35	Closed	-$66K	–	3826
2017 Q3	$66K	Buy	+35	New	+$72.4K	﹤0.01%	3386

Other funds holding CRVO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Millennium Management's CRVO Position: Q2 2026 in Review

Millennium Management sold out of CervoMed (CRVO) in Q2 2026, closing a stake of 208,908 shares — an estimated $823K sold.

Millennium Management first reported a position in CRVO in Q3 2017 and held it in 11 quarters. The position peaked at $823K in Q1 2026. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

Millennium Management reported no remaining CervoMed position as of Q2 2026 after selling out during the quarter.
Millennium Management sold 208,908 CervoMed shares in Q2 2026, an estimated $823K.
Millennium Management first reported a position in CervoMed in Q3 2017 and held it in 11 quarters.
Millennium Management's CervoMed position peaked at $823K in Q1 2026.
37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.